Unknown

Dataset Information

0

Engineered humanized diabodies for microPET imaging of prostate stem cell antigen-expressing tumors.

ABSTRACT: We have previously demonstrated preclinical in vivo targeting of prostate stem cell antigen (PSCA) using a humanized anti-PSCA 2B3 monoclonal antibody (mAb). However, humanization resulted in 5-fold loss of apparent affinity relative to the parental mAb (1 nM). In this study, diabodies (scFv dimers of 55 kDa) were generated from 2B3 including variants with different linker lengths as well as back-mutations to original murine residues to improve affinity. Parental 2B3 (p2B3) and back-mutated 2B3 (bm2B3) diabodies (Dbs) with five- or eight-amino acid linkers (p2B3-Db5, p2B3-Db8, bm2B3-Db5 and bm2B3-Db8) were evaluated for binding to PSCA by flow cytometry and affinities were determined by surface plasmon resonance. Back-mutation restored the affinity from 5.4 to 1.9 nM. Stability, evaluated by size exclusion, revealed that diabodies with eight-residue linkers existed as a mixture of dimeric and monomeric species at low concentrations (

SUBMITTER: Leyton JV 

PROVIDER: S-EPMC2644405 | biostudies-literature | 2009 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Engineered humanized diabodies for microPET imaging of prostate stem cell antigen-expressing tumors.

Leyton Jeffrey V JV   Olafsen Tove T   Sherman Mark A MA   Bauer Karl B KB   Aghajanian Patrick P   Reiter Robert E RE   Wu Anna M AM  

Protein engineering, design & selection : PEDS 20081028 3

We have previously demonstrated preclinical in vivo targeting of prostate stem cell antigen (PSCA) using a humanized anti-PSCA 2B3 monoclonal antibody (mAb). However, humanization resulted in 5-fold loss of apparent affinity relative to the parental mAb (1 nM). In this study, diabodies (scFv dimers of 55 kDa) were generated from 2B3 including variants with different linker lengths as well as back-mutations to original murine residues to improve affinity. Parental 2B3 (p2B3) and back-mutated 2B3  ...[more]

Similar Datasets

Unknown 111In- and IRDye800CW-Labeled PLA-PEG Nanoparticle for Imaging Prostate-Specific Membrane Antigen-Expressing Tissues.
| S-EPMC5516902 | biostudies-literature
Unknown A novel chimeric antigen receptor against prostate stem cell antigen mediates tumor destruction in a humanized mouse model of pancreatic cancer.
| S-EPMC4270113 | biostudies-literature
Unknown Prostate-specific membrane antigen (PSMA)-targeted photodynamic therapy enhances the delivery of PSMA-targeted magnetic nanoparticles to PSMA-expressing prostate tumors.
| S-EPMC7868004 | biostudies-literature
Unknown Bispecific Antibody Conjugated Manganese-Based Magnetic Engineered Iron Oxide for Imaging of HER2/neu- and EGFR-Expressing Tumors.
| S-EPMC4679359 | biostudies-literature
Unknown 18F-FDG microPET imaging detects early transient response to an IGF1R inhibitor in genetically engineered rhabdomyosarcoma models.
| S-EPMC3924883 | biostudies-literature
Unknown Monitoring luciferase-labeled human prostate stem cell antigen-expressing tumor growth in a mouse model.
| S-EPMC3820663 | biostudies-literature
Unknown A dextran-based probe for the targeted magnetic resonance imaging of tumours expressing prostate-specific membrane antigen.
| S-EPMC5810963 | biostudies-literature
Unknown Noninvasive Imaging of PSMA in prostate tumors with (89)Zr-Labeled huJ591 engineered antibody fragments: the faster alternatives.
| S-EPMC4224519 | biostudies-other
Unknown A humanized antibody for imaging immune checkpoint ligand PD-L1 expression in tumors.
| S-EPMC4891115 | biostudies-literature
Unknown Prostate stem cell antigen-targeted nanoparticles with dual functional properties: in vivo imaging and cancer chemotherapy.
| S-EPMC3415325 | biostudies-literature